Alcohol (EtG)

The amount of alcohol consumed is the dominant determinant of how long EtG remains detectable. A single standard drink may produce a urine EtG concentration that crosses the 100 ng/mL threshold for roughly 24 hours and disappears below the 500 ng/mL threshold even sooner. Sustained drinking — for example, several drinks over an evening — typically produces detectable EtG for 48–72 hours at common clinical cutoffs, and a heavy intoxication episode can produce EtG above the 100 ng/mL threshold approaching the 80-hour upper bound that has given the test its common marketing name. Program designers should choose a cutoff based on what level of drinking they want the test to catch.

Cutoff selection is itself a major factor in the apparent detection window. The same drinking event will produce a positive result for substantially longer at 100 ng/mL than at 500 ng/mL. The 500 ng/mL cutoff is generally chosen by programs that want to minimize false positives from incidental alcohol exposure — mouthwash, hand sanitizer, certain food preparations, kombucha, and some over-the-counter medications can produce low-level urinary EtG in some donors. The 100 ng/mL cutoff is more sensitive but correspondingly more vulnerable to those incidental-exposure positives, and programs using it generally have a defined process for evaluating low-positive results in context. The 250 ng/mL middle option balances the two concerns and is widely used in substance-use treatment settings.

Renal function and hydration influence urinary EtG concentration just as they influence other urinary analytes. EtG is renally cleared, so impaired kidney function can extend the apparent detection window by slowing excretion. Heavy dilution of urine — through unusually high fluid intake or any other cause — can push EtG below the cutoff in a specimen that would otherwise have tested positive, which is why programs concerned with abstinence verification rely on specimen validity testing (creatinine, specific gravity) alongside the EtG result. A dilute specimen is generally treated as inconclusive and recollected rather than reported as negative.

Body weight, sex, age, and individual variation in glucuronidation enzymes all contribute smaller modifying effects. Female donors tend to produce slightly higher EtG concentrations per gram of ethanol consumed than male donors of the same body weight, reflecting differences in body water composition and first-pass ethanol metabolism. Older donors and those with hepatic impairment may show altered EtG kinetics, though the direction of the effect is variable and individual. Programs should treat EtG results as one component of a broader monitoring picture rather than relying on a single specimen for a definitive determination about a single drinking event.

EtG is not part of SAMHSA's Mandatory Guidelines for federal workplace drug testing, so there is no single "federal" EtG cutoff comparable to the SAMHSA THC or amphetamine numbers. Industry practice has converged on three common screening thresholds: 100 ng/mL, 250 ng/mL, and 500 ng/mL. The 500 ng/mL cutoff was the original consensus value recommended in early SAMHSA advisories on EtG testing as the level above which incidental-exposure false positives become substantially less likely. The 100 and 250 ng/mL cutoffs are used in programs that prioritize sensitivity to recent drinking and have processes in place to evaluate borderline results.

Confirmation testing is performed by LC-MS/MS at a SAMHSA-certified or equivalently credentialed clinical laboratory. Confirmation cutoffs are typically set at or near the screening cutoff (commonly 100 or 250 ng/mL for confirmation depending on program), and most laboratories also report ethyl sulfate (EtS) on the same specimen to corroborate the finding. A specimen positive for both EtG and EtS at corresponding concentrations is a stronger inference of alcohol consumption than EtG alone. Magenta's 80-hour EtG dip card is calibrated to the 500 ng/mL screening cutoff by default; talk to us about lower-cutoff options for programs that need them.

SAMHSA has issued advisory guidance on the interpretation of EtG results, cautioning programs not to rely on a single low-positive result as definitive evidence of drinking because of the well-documented potential for incidental-exposure positives. That guidance is widely cited in clinical practice and forensic litigation and is worth reading in full before standing up an EtG program. The practical implication is that programs commonly pair EtG with at least one additional data point — a confirmation EtS result, a follow-up specimen, or clinical context — before taking adverse action based on a borderline finding.

Lateral-flow immunoassay is the workhorse format for point-of-care EtG testing. The Magenta 80-hour EtG dip card uses an anti-EtG antibody that, in the presence of EtG above the device's cutoff, prevents accumulation of labeled conjugate at the test line. As with other Magenta point-of-care devices, no test line indicates a positive result, a visible test line indicates negative, and the control line confirms reagent function. Result time is approximately five minutes. The format is identical to that used for other urinary analytes, which is what allows EtG to be incorporated as one channel on multi-analyte cups.

Cross-reactivity with non-ethanol compounds is generally limited because the EtG molecule is structurally distinct. The cross-reactivity that does matter in clinical practice is exposure-driven rather than chemical: incidental ethanol exposure from mouthwash, hand sanitizer, certain over-the-counter cough preparations, kombucha and other fermented beverages, vanilla extract, and some food-preparation alcohols can produce low-level urinary EtG that may exceed the 100 ng/mL cutoff in some donors. SAMHSA's EtG advisory and subsequent peer-reviewed literature document these exposures and recommend caution when interpreting low-positive results. Programs commonly mitigate this risk by selecting a higher cutoff (250 or 500 ng/mL) or by establishing a defined low-positive review process.

Confirmation testing is performed by LC-MS/MS, which identifies and quantifies EtG by its specific mass spectrum and, in most laboratory protocols, simultaneously measures ethyl sulfate (EtS). The EtG-to-EtS ratio is sometimes used to differentiate true alcohol consumption from urinary post-collection ethanol fermentation, a rare but documented artifact in glucose-positive specimens contaminated with yeast or certain bacteria. Mass spectrometry confirmation is the standard of practice before any adverse action — termination, return-to-treatment intensification, custody decisions, licensure consequences — is based on an EtG result.

Specimen validity testing is essential for EtG programs because urinary dilution and adulteration can both defeat or distort the result. Creatinine and specific gravity are the primary integrity markers; pH and oxidant adulterant pads add additional protection. Magenta's adulteration-panel cups integrate these checks alongside the analyte channels. A dilute specimen with low creatinine and low specific gravity is generally treated as inconclusive and recollected, particularly in abstinence-monitoring contexts where the donor has an incentive to dilute. Specimen-temperature checks at the time of collection are also standard practice.

Programs evaluating EtG should remember that EtG and ethanol testing answer different questions. A breath or blood ethanol test (the matrix used under 49 CFR Part 40 and most workplace alcohol testing) detects current intoxication and clears within hours. EtG detects historical consumption over the prior several days. Neither test substitutes for the other. Some programs use both — breath ethanol for current-impairment determinations, EtG for abstinence verification — and Magenta supplies both formats for that combined use case.